Efficacy and safety of concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced nasopharyngeal cancers


Baykara M., Buyukberber S., Ozturk B., Coskun U., Kaplan M. A. , Unsal D. K. , ...More

TUMORI, vol.99, no.4, pp.469-473, 2013 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 99 Issue: 4
  • Publication Date: 2013
  • Doi Number: 10.1700/1361.15096
  • Title of Journal : TUMORI
  • Page Numbers: pp.469-473

Abstract

Aims and background. Chemoradiation using cisplatin-based regimens has become the standard care in the treatment of nasopharyngeal cancers, The impact of taxanes as radiosensitizing agents with concurrent chemoradiation regimens is unknown. We retrospectively evaluated the efficacy and tolerability of weekly cisplatin + docetaxel combination with chemoradiation in locally advanced nasopharyngeal cancers.